Form 4 Tracker
Liquidia Corp
LQDA

66 insider filings · Latest: Jun 22, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Jun 1, 2026Jun 3 8:30 PMArthur S KirschDirector
Sale
15,000$60.22$903.3K15,000(I)

View →

Jun 1, 2026Jun 1 1:56 PMKIRSCH ARTHUR S
Proposed Sale
30,000$61.37$1.8M

View →

May 27, 2026May 28 8:30 PMRoger JeffsDirector, Chief Executive Officer
Sale
6,428$62.18$399.7K1,041,667(I)

View →

May 21, 2026May 26 10:17 PMRaman SinghDirector
Sale
29,494$60.13$1.8M38,755(D)

View →

May 26, 2026May 26 10:16 PMRoger JeffsDirector, Chief Executive Officer
Sale
25,000$60.38$1.5M1,048,095(I)

View →

May 22, 2026May 26 10:16 PMRoger JeffsDirector, Chief Executive Officer
Sale
25,000$61.52$1.5M1,073,095(I)

View →

May 21, 2026May 26 10:16 PMRoger JeffsDirector, Chief Executive Officer
Sale
25,000$61.13$1.5M1,098,095(I)

View →

May 21, 2026May 21 9:12 PMRAMANDEEP SINGH
Proposed Sale
29,494$60.13$1.8M

View →

May 19, 2026May 21 12:51 AMCaligan Partners LPDirector, 10% Owner, Other
Purchase
5,300$59.98$317.9K8,138,951(I)

View →

May 19, 2026May 21 12:51 AMCaligan Partners LPDirector, 10% Owner, Other
Sale
5,300$59.98$317.9K8,133,651(I)

View →

May 20, 2026May 20 10:55 PMRoger JeffsDirector, Chief Executive Officer
Sale
25,000$61.30$1.5M1,123,095(I)

View →

May 19, 2026May 20 10:55 PMRoger JeffsDirector, Chief Executive Officer
Sale
25,000$58.65$1.5M1,148,095(I)

View →

May 18, 2026May 20 10:55 PMRoger JeffsDirector, Chief Executive Officer
Sale
25,000$56.77$1.4M1,173,095(I)

View →

May 20, 2026May 20 8:37 PMSERENDIPITY BIOPHARMA LLC
Proposed Sale
106,428$59.98$6.4M

View →

May 15, 2026May 15 10:59 PMRoger JeffsDirector, Chief Executive Officer
Sale
25,000$57.04$1.4M1,198,095(I)

View →

May 14, 2026May 15 10:59 PMRoger JeffsDirector, Chief Executive Officer
Sale
25,000$58.62$1.5M1,223,095(I)

View →

May 13, 2026May 15 10:59 PMRoger JeffsDirector, Chief Executive Officer
Sale
25,000$56.29$1.4M1,248,095(I)

View →

May 14, 2026May 14 8:26 PMSERENDIPITY BIOPHARMA LLC
Proposed Sale
100,000$57.59$5.8M

View →

May 11, 2026May 13 8:30 PMStephen M BlochDirector
Sale
318,893$50.23$16.0M1,870,042(I)

View →

May 12, 2026May 12 10:52 PMRoger JeffsDirector, Chief Executive Officer
Sale
25,000$54.04$1.4M1,273,095(I)

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Jan 16, 2026Jan 21 11:27 PMDana BoyleChief Accounting Officer
Grant/Award
35,59235,592(D)

View →

Jan 16, 2026Jan 21 11:24 PMRoger JeffsDirector, Chief Executive Officer
Grant/Award
173,016173,016(D)

View →

Jan 16, 2026Jan 21 11:23 PMMichael KasetaCFO and COO
Grant/Award
88,98088,980(D)

View →

Jan 16, 2026Jan 21 11:20 PMSarah KreppChief Human Resource Officer
Grant/Award
35,59235,592(D)

View →

Jan 16, 2026Jan 21 11:18 PMScott MoomawChief Commercial Officer
Grant/Award
49,43349,433(D)

View →

Jan 16, 2026Jan 21 11:16 PMRajeev SaggarChief Medical Officer
Grant/Award
49,43349,433(D)

View →

Jan 16, 2026Jan 21 11:16 PMRussell SchundlerGeneral Counsel
Grant/Award
49,43349,433(D)

View →

← Previous

Page 2 of 2